CYMBALTA caps 30 mg 28 pce

7680569830060 CH-56983 N06AX21 01.06.0.
CYMBALTA caps 30 mg 28 pce
CYMBALTA caps 30 mg 28 pce
CYMBALTA caps 30 mg 28 pce
1 / 3
google

Details

Product number
5698301
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
duloxetinum 30 mg ut duloxetini hydrochloridum, saccharum, hypromellosi acetas succinas, hypromellosum, sacchari sphaerae, talcum, triethylis citras, E 171, matériel de la capsule: E 132, E 171, gelatina, natrii laurilsulfas, encre: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), E 172 (flavum), pro capsula corresp. saccharum 56 mg, natrium 0.0055 mg.

Articles (1)

Cymbalta 30 mg, gélules gastrorésistantes
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/02/2025
Patient information leaflet
Français
12/02/2025
Patient information leaflet
Italien
12/02/2025
Professional SmPC
Allemand
12/02/2025
Professional SmPC
Français
12/02/2025
Professional SmPC
Italien
12/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
56.0 MG Substance HBESI
(N/A)
0.0055 MG Substance HBESI

Reimbursement information

Public price
CHF 32.40
Specialties list
Yes
Generic
No
SL addition date: 01/06/2006

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
56983
Drug name
Cymbalta, gélules gastrorésistantes
Galenic form
KAHAM
ATC Code
N06AX21
Authorization status
Z
Dispensation category
B
First authorization
24/11/2005
Authorization expiration date
01/06/2026
IT number
01.06.0.
Domain
Human medicine
Field of application
Antidepressivum, Schmerzen bei diabetischer Neuropathie, generalisierte Angststörung

Packaging details

Description (FR)
CYMBALTA caps 30 mg 28 pce
Description (DE)
CYMBALTA Kaps 30 mg 28 Stk
Market launch
24/11/2005
Narcotic (BTM)
No

Available generics

Duloxetin Axapharm, magensaftresistente Hartkapseln
CHF 27.50
View
Duloxetin Axapharm, magensaftresistente Hartkapseln
CHF 48.35
View
Duloxetin Axapharm, magensaftresistente Hartkapseln
CHF 26.95
View
Duloxetin Axapharm, magensaftresistente Hartkapseln
CHF 36.45
View
Duloxetin Axapharm, magensaftresistente Hartkapseln
CHF 74.95
View
Duloxetin-Mepha, magensaftresistente Hartkapseln
CHF 28.55
View
Duloxetin-Mepha, magensaftresistente Hartkapseln
CHF 50.80
View
Duloxetin-Mepha, magensaftresistente Hartkapseln
CHF 50.80
View
Duloxetin-Mepha, magensaftresistente Hartkapseln
CHF 24.10
View
Duloxetin-Mepha, magensaftresistente Hartkapseln
CHF 37.80
View

Other packaging sizes

CYMBALTA caps 60 mg 14 pce
14 KAP
View
CYMBALTA caps 60 mg 28 pce
28 KAP
View
CYMBALTA caps 60 mg 84 pce
84 KAP
View